Susquehanna International Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$802K Sell
98,592
-17,921
-15% -$154K ﹤0.01% 8470
2025
Q4
$1.21M Sell
116,513
-270,443
-70% -$2.84M ﹤0.01% 6752
2025
Q3
$3.42M Buy
386,956
+230,540
+147% +$1.64M 0.01% 4729
2025
Q2
$903K Sell
156,416
-15,032
-9% -$92.1K ﹤0.01% 7702
2025
Q1
$1.13M Buy
171,448
+86,934
+103% +$677K ﹤0.01% 6932
2024
Q4
$736K Buy
84,514
+60,193
+247% +$866K ﹤0.01% 7708
2024
Q3
$475K Sell
24,321
-19,538
-45% -$396K ﹤0.01% 8579
2024
Q2
$903K Sell
43,859
-551,020
-93% -$11.3M ﹤0.01% 6830
2024
Q1
$12.7M Buy
594,879
+530,196
+820% +$10.3M 0.02% 2301
2023
Q4
$930K Sell
64,683
-26,681
-29% -$262K ﹤0.01% 7158
2023
Q3
$833K Sell
91,364
-3,315
-4% -$33.7K ﹤0.01% 7056
2023
Q2
$1M Sell
94,679
-15,266
-14% -$181K ﹤0.01% 6674
2023
Q1
$1.34M Buy
109,945
+48,913
+80% +$610K ﹤0.01% 6075
2022
Q4
$757K Sell
61,032
-47,338
-44% -$688K ﹤0.01% 6800
2022
Q3
$1.48M Buy
+108,370
New +$1.67M ﹤0.01% 5633
2022
Q2
Sell
-61,529
Closed -$885K 13608
2022
Q1
$989K Sell
61,529
-118,432
-66% -$1.71M ﹤0.01% 7145
2021
Q4
$2.52M Buy
179,961
+105,886
+143% +$1.72M ﹤0.01% 4983
2021
Q3
$1.39M Buy
74,075
+33,975
+85% +$640K ﹤0.01% 6686
2021
Q2
$836K Buy
40,100
+25,005
+166% +$621K ﹤0.01% 8253
2021
Q1
$427K Sell
15,095
-128,658
-89% -$4.07M ﹤0.01% 9836
2020
Q4
$4.7M Sell
143,753
-112,791
-44% -$3.96M 0.01% 3499
2020
Q3
$7.86M Buy
256,544
+187,986
+274% +$4.15M 0.01% 2493
2020
Q2
$1.12M Buy
68,558
+46,544
+211% +$671K ﹤0.01% 5656
2020
Q1
$219K Buy
+22,014
New +$252K ﹤0.01% 8524
2019
Q4
Sell
-18,697
Closed -$277K 10301
2019
Q3
$284K Sell
18,697
-8,359
-31% -$149K ﹤0.01% 8406
2019
Q2
$533K Buy
+27,056
New +$449K ﹤0.01% 7129
2019
Q1
Hold
0
9754
2018
Q4
Hold
0
9868
2018
Q3
Hold
0
10102
2018
Q2
Hold
0
10314
2017
Q2
Sell
-14,156
Closed -$125K 9775
2017
Q1
$125K Buy
+14,156
New +$104K ﹤0.01% 8294

Other funds holding KURA